Oncology Institute Inc (NASDAQ: TOI) is -89.04% lower on its value in year-to-date trading and has touched a low of $0.13 and a high of $2.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TOI stock was last observed hovering at around $0.20 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $0.22, the stock is 11.75% and -8.37% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.73 million and changing 9.46% at the moment leaves the stock -61.71% off its SMA200. TOI registered -87.30% loss for a year compared to 6-month loss of -48.00%. The firm has a 50-day simple moving average (SMA 50) of $0.2457 and a 200-day simple moving average (SMA200) of $0.59052.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 45.19% gain in the last 1 month and extending the period to 3 months gives it a -25.19%, and is 17.68% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.44% over the week and 20.16% over the month.
Oncology Institute Inc (TOI) has around 800 employees, a market worth around $18.48M and $378.93M in sales. Profit margin for the company is -15.17%. Distance from 52-week low is 78.29% and -91.06% from its 52-week high. The company has generated returns on investments over the last 12 months (-43.66%).
45.0 institutions hold shares in Oncology Institute Inc (TOI), with institutional investors hold 59.16% of the company’s shares. The shares outstanding are 75.56M, and float is at 36.80M with Short Float at 0.47%. Institutions hold 47.59% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.75 million shares valued at $2.19 million. The investor’s holdings represent 6.4005 of the TOI Shares outstanding. As of 2024-06-30, the second largest holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 3.36 million shares valued at $1.55 million to account for 4.5263 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 1.78 million shares representing 2.4025 and valued at over $0.82 million, while KENT LAKE CAPITAL LLC holds 2.3574 of the shares totaling 1.75 million with a market value of $0.81 million.
Oncology Institute Inc (TOI) Insider Activity
The most recent transaction is an insider purchase by Hively Brad, the company’s Director. SEC filings show that Hively Brad bought 250,000 shares of the company’s common stock on Nov 26 ’24 at a price of $0.17 per share for a total of $42500.0. Following the purchase, the insider now owns 0.62 million shares.
Oncology Institute Inc disclosed in a document filed with the SEC on Dec 02 ’24 that Hively Brad (Director) bought a total of 50,000 shares of the company’s common stock. The trade occurred on Dec 02 ’24 and was made at $0.15 per share for $7500.0. Following the transaction, the insider now directly holds 0.67 million shares of the TOI stock.
Still, SEC filings show that on Jan 29 ’24, Havencrest Healthcare Partners (10% Owner) disposed off 8,637 shares at an average price of $2.12 for $18310.0. The insider now directly holds 0 shares of Oncology Institute Inc (TOI).
